Kisqali 400 MG daily dose UU 42S
Ended Awarded Last action
- Contract number
- SPE2DR26F22KE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,639
Award facts
- Contract value 100% obligated
- $19,639.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $19,639.24 delivery order to Amerisourcebergen Drug Corp on February 13, 2026, for supply of Kisqali 400 mg daily dose (42-count units).
Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of March 9, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26F22KE?
SPE2DR26F22KE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 13, 2026.
How much is contract SPE2DR26F22KE worth?
The government has obligated $19,639 on SPE2DR26F22KE.
Is contract SPE2DR26F22KE an order under another contract?
Yes. SPE2DR26F22KE is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F22KE competed?
The extent of competition for SPE2DR26F22KE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award